Literature DB >> 437428

Hepatitis B e antigen, DNA polymerase activity, and infection of household contacts with hepatitis B virus.

R P Perrillo, L Gelb, C Campbell, W Wellinghoff, F R Ellis, L Overby, R D Aach.   

Abstract

To determine if the presence of hepatitis B e antigen (HBeAg) and elevated DNA polymerase activity in the serum of chronic HBeAg carriers indicate increased contagiousness in a household setting, the household contacts of 74 carriers were prospectively evaluated for serologic evidence of hepatitis B infection. Thirty of the HBsAg carriers had HBeAg and 44 had anti-HBe. Twenty-eight HBeAg-positive carriers regularly demonstrated elevated DNA polymerase when serially drawn serum samples were analyzed. None of the anti-HBE-positive carriers demonstrated elevation of DNA polymerase activity. Both household contacts of HBeAg-positive and anti-HBe-positive carriers demonstrated serologic evidence of hepatitis B infection (HBsAg, anti-HBs, and anti-HBc). However, infection was significantly more frequent among spouses and sexual partners of carriers who had either HBeAg (P less than 0.001) or elevated DNA polymerase activity (P less than 0.001). Thus, the data indicate that a particular subpopulation of spouses and sexual partners of hepatitis B carriers are at significantly greater risk for acquiring infection.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 437428

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  12 in total

1.  Hepatitis B in the family.

Authors:  J Milas; D Ropac; R Mulić; V Milas; I Valek; I Zorić; K Kozul
Journal:  Eur J Epidemiol       Date:  2000-03       Impact factor: 8.082

Review 2.  Exposure to hepatitis B: review of current concepts.

Authors:  F H Zimmerman; G P Wormser
Journal:  Bull N Y Acad Med       Date:  1989-09

Review 3.  Interferon in the management of chronic hepatitis B.

Authors:  R P Perrillo
Journal:  Dig Dis Sci       Date:  1993-04       Impact factor: 3.199

4.  Cost without benefit? The introduction of hepatitis B vaccine in Canada.

Authors:  R A Coates; J G Rankin
Journal:  Can Med Assoc J       Date:  1983-05-15       Impact factor: 8.262

5.  Chronic viral hepatitis B in childhood. II. Immunological studies in serum and liver tissue and family studies.

Authors:  C Bosch; M Becker; H W Rotthauwe; W Arnold; G Hess
Journal:  Eur J Pediatr       Date:  1981-03       Impact factor: 3.183

6.  Hepatitis B virus markers on dried blood spots. A new tool for epidemiological research.

Authors:  E Villa; R Cartolari; S Bellentani; P Rivasi; G Casolo; F Manenti
Journal:  J Clin Pathol       Date:  1981-07       Impact factor: 3.411

7.  Effects of prednisolone/azathioprine in chronic hepatitis B viral infection.

Authors:  I V Weller; M F Bassendine; A K Murray; A Craxi; H C Thomas; S Sherlock
Journal:  Gut       Date:  1982-08       Impact factor: 23.059

8.  Hepatitis B infection in households of acute cases.

Authors:  K T Goh; J L Ding; E H Monteiro; C J Oon
Journal:  J Epidemiol Community Health       Date:  1985-06       Impact factor: 3.710

9.  Hepatitis B virus DNA in saliva, urine, and seminal fluid of carriers of hepatitis B e antigen.

Authors:  P Karayiannis; D M Novick; A S Lok; M J Fowler; J Monjardino; H C Thomas
Journal:  Br Med J (Clin Res Ed)       Date:  1985-06-22

10.  Hepatitis B in Wisconsin male prisoners: considerations for serologic screening and vaccination.

Authors:  R F Anda; S B Perlman; D J D'Alessio; J P Davis; V N Dodson
Journal:  Am J Public Health       Date:  1985-10       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.